Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John W Funder

Showing results (31-40 of 133) with videos related to

Pageof 14
Sort By:
Hypertension (Dallas, Tex. : 1979)|April 9, 2014
Sensitivity to aldosterone: plasma levels are not the full storyJohn W Funder
The Lancet. Diabetes & Endocrinology|November 26, 2016
Primary aldosteronism as a public health issueJohn W Funder
Hypertension (Dallas, Tex. : 1979)|October 26, 2018
Idiopathic HyperaldosteronismJohn W Funder
Clinical and Experimental Pharmacology & Physiology|March 1, 2008
Translational research goes both ways: lessons from clinical studiesJohn W Funder
Endocrine|July 24, 2012
The case against aldosterone: not provenJohn W Funder
Science (New York, N.Y.)|February 12, 2011
Medicine. The genetics of primary aldosteronismJohn W Funder
Hypertension (Dallas, Tex. : 1979)|January 19, 2011
GPR30, mineralocorticoid receptors, and the rapid vascular effects of aldosteroneJohn W Funder
Endocrinology|September 24, 2010
Minireview: Aldosterone and mineralocorticoid receptors: past, present, and futureJohn W Funder
Hypertension (Dallas, Tex. : 1979)|January 14, 2009
Reconsidering the roles of the mineralocorticoid receptorJohn W Funder
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|October 25, 2017
Primary Aldosteronism: The Next Five YearsJohn W Funder
Pageof 14

Showing results (31-40 of 133) with videos related to

Sort By:
Pageof 14
Hypertension (Dallas, Tex. : 1979)|April 9, 2014
Sensitivity to aldosterone: plasma levels are not the full storyJohn W Funder
The Lancet. Diabetes & Endocrinology|November 26, 2016
Primary aldosteronism as a public health issueJohn W Funder
Hypertension (Dallas, Tex. : 1979)|October 26, 2018
Idiopathic HyperaldosteronismJohn W Funder
Clinical and Experimental Pharmacology & Physiology|March 1, 2008
Translational research goes both ways: lessons from clinical studiesJohn W Funder
Endocrine|July 24, 2012
The case against aldosterone: not provenJohn W Funder
Science (New York, N.Y.)|February 12, 2011
Medicine. The genetics of primary aldosteronismJohn W Funder
Hypertension (Dallas, Tex. : 1979)|January 19, 2011
GPR30, mineralocorticoid receptors, and the rapid vascular effects of aldosteroneJohn W Funder
Endocrinology|September 24, 2010
Minireview: Aldosterone and mineralocorticoid receptors: past, present, and futureJohn W Funder
Hypertension (Dallas, Tex. : 1979)|January 14, 2009
Reconsidering the roles of the mineralocorticoid receptorJohn W Funder
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|October 25, 2017
Primary Aldosteronism: The Next Five YearsJohn W Funder
Pageof 14